Taipei, Taiwan – December 16th, 2024 – We are deeply pleased to have collaborated with Toru Jay Seo, Ph.D., MBA, and the Newsight Tech Angels over the past year. This partnership has not only been a fruitful one but also a reflection of our shared commitment to advancing innovation and fostering cross-border growth in the biotech sector. The recent signing of the Memorandum of Understanding (MoU) between CellTech Accelerator and Newsight Tech Angles is a significant milestone, formalizing our hard work and collaboration that have already been put into place. It symbolizes the unity of our visions and goals, as well as the promise of continued progress as we move forward together.
The MoU marks a deepened commitment to working alongside exceptional teams to bring transformative solutions to the biotech industry. As we look ahead, we are filled with great anticipation for what the future holds. Together, we aim to catalyze innovation, inspire creative breakthroughs, and promote a forward-thinking approach that will not only benefit our respective organizations but the broader biotech ecosystem as well. The integration of our resources and expertise will pave the way for new advancements in biotech, drug discovery, and the improvement of medical technologies.
Our commitment to biotech startups goes beyond operational support by providing a platform for fundraising, ensuring these ventures have the capital needed to scale and succeed. Funding is often a major barrier, and we aim to connect startups with investors who understand the industry’s potential. At the core of this partnership is collaboration to accelerate growth. The foundation we’ve built will serve as a launchpad for future endeavors, and we invite investors, biotech companies, and research institutions to join us. Together, we can create an ecosystem that fosters creativity, supports risk-taking, and drives groundbreaking discoveries that will shape the future of medicine and drug development.
At CellTech Accelerator, we strive to strengthen Taiwan-Japan biotech partnerships by supporting Japanese startups in establishing a presence in Taiwan and fostering a closer collaborative ecosystem. We look forward to hosting more international exchange events with our partners to drive the growth of the Asian biotech industry. If you’re interested in the Japanese biotech sector, contact us to explore potential collaboration opportunities.
About Newsight Tech Angels
Newsight Tech Angels seeks to cultivate a dynamic startup ecosystem by supporting the commercialization and global expansion of Japan’s cutting-edge technologies and drug discovery innovations, which often remain overlooked due to funding challenges. We help bring promising overseas biotech ventures to the Japanese market, making angel investments that foster a vibrant, cross-border ecosystem.
For more information, please visit: https://ntangels.com/